In the light of the above assessment and the conclusion in our previous study that MM/GBSA rescoring has good capability to distinguish the correct protein protein binding structures from the decoys, it would suggest to be an efficient protocol of using HawkRank followed by the MM/GBSA rescoring to improve the predictions of protein protein docking.
The drug-binding structures were extracted from SuperTarget (Gunther et al., 2008).
In accordance with the data from the on-array streptavidin-binding assay, mutant C12G23 is structurally distinct from St-2-1 and has a much reduced binding affinity, whereas mutants A12T23 and G12C23 are structurally similar to St-2-1 and retain a similar binding affinity (DNA structures from http://mfold.rna.albany.edu/?q=mfold/dna-folding-form).
We have developed a computational method to extract implicit structural signatures of a drug binding site from an ensemble of structures of proteins to which this drug binds.
The crystal structure of TATA binding protein (TBP) from a mesothermophilic archaeon, Sulfolobus acidocaldarius, has been determined at a resolution of 2.0 Å with an R factor of 20.9%.
The two mechanisms are illustrated in the lower part of Figure 3 by structure data from a binding and a non-binding C1 case, with electrostatic positive and negative isosurfaces superimposed and hydrophobic residues highlight in yellow.
This is the case in the structure of the nucleotide binding RCK domain from a K+ transporter, in which only the AMP portion of a bound NAD+ can be defined (Roosild et al., 2002; Albright et al., 2006).
This is accomplished by three steps: (1) docking of all possible 9-mer core segments from the peptide into the MHC protein to predict the structures of the bound complexes, (2) machine-learning based scoring to predict the 9-mer binding affinities based on the structures from step (1), and (3) calculating the final binding score as the maximum score over all 9-mer segments.
A subset of structures from most ensembles revealed Ca2+ binding sites (see Figure 4).
In these cases, sRNAs may activate translation by liberating the ribosome-binding site from an inhibitory stem-loop structure situated at the 5' mRNA region [6], [8].
